Advancement in Enterotoxigenic Escherichia coli (ETEC) Vaccines
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Molecular Microbiology and Immunology".
Deadline for manuscript submissions: 30 June 2026 | Viewed by 1138
Special Issue Editor
Special Issue Information
Dear Colleagues,
Enterotoxigenic Escherichia coli (ETEC) is a major cause of diarrhea in children in developing countries and in travellers to these regions. It is also a major cause of diarrhea in piglets and calves. Intensive ongoing efforts aim to develop safe and effective ETEC vaccines for use in travellers as well as in children in endemic areas. Several promising ETEC candidate vaccines have reached the stage of Phase 1-2b clinical trials in humans, with promising results. Efforts to improve ETEC vaccines for use in livestock are also in progress. This Special Issue will address the following aims:
- Provide an update of the epidemiology of ETEC disease in populations in developing countries and in travellers to these regions as a background for ETEC vaccine development.
- Present different vaccine candidates, including new putative vaccine antigens, as well as promising adjuvants.
- Explore different approaches to develop combined enteric vaccines, e.g., ETEC and Shigella.
- Describe recent, ongoing and planned clinical trials of ETEC vaccines in target population (travellers to, and children and adults in ETEC endemic areas).
- Outline the issue of ETEC disease in livestock and efforts to develop improved ETEC vaccines.
Dr. Ann-Mari Svennerholm
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ETEC vaccine candidates
- protective antigens
- adjuvants
- clinical trial phase 1-2b
- ETEC epidemiology
- travellers
- children in LMIC
- ETEC in animals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
